Using a Special Drug to Stop Lung Bleeding
Author Information
Author(s): Estella Ángel, Jareño Antonio, Perez-Bello Fontaiña Luis
Primary Institution: Critical Care Unit, Hospital of Jerez, Spain
Hypothesis
Can intrapulmonary administration of recombinant activated factor VII effectively treat diffuse alveolar hemorrhage?
Conclusion
Intrapulmonary administration of rFVIIa is effective in controlling life-threatening diffuse alveolar hemorrhage without causing thrombotic complications.
Supporting Evidence
- Immediate cessation of bleeding was observed after rFVIIa administration.
- Both patients were discharged from the ICU without further episodes of bleeding.
Takeaway
Doctors used a special medicine to help two patients with serious lung bleeding, and it worked well without causing any new problems.
Methodology
Two cases of diffuse alveolar hemorrhage were treated with intrapulmonary rFVIIa administered via bronchoscopy.
Potential Biases
Potential bias due to the lack of a control group and reliance on case reports.
Limitations
The study is based on only two cases, limiting the generalizability of the findings.
Participant Demographics
One female patient aged 39 with a history of leukemia and one male patient aged 46 with multiple health issues including HIV and liver cirrhosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website